Cytokines and fibrinolytic enzymes in tuberculous and parapneumonic effusions

Clinical Immunology

Volumn 116, Issue 2, 2005, Pages 166-173

  Lin, Fang Chi ^a,c   Chen, Yi Chu ^b   Chen, Funn Juh ^b   Chang, Shi Chuan ^b,c  

^a Yuan Shan Veterans Hospital   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Chemokines; Cytokines; Empyema; Fibrinolysis; Parapneumonic effusion; Pleural effusions; Pleural thickening; Tuberculosis; Tuberculous pleurisy

Indexed keywords

CYTOKINE; FIBRIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; PLASMIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBRIN DEPOSITION; FIBRIN FORMATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PLEURA EFFUSION; PLEURA EMPYEMA; PLEURAL FIBROSIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; QUANTITATIVE ANALYSIS; TUBERCULOUS PLEURISY;

ADULT; AGED; AGED, 80 AND OVER; BRONCHIECTASIS; CHEMOKINE CCL2; CYTOKINES; EMPYEMA, PLEURAL; EMPYEMA, TUBERCULOUS; FEMALE; HUMANS; INTERLEUKINS; LUNG; LUNG ABSCESS; MACROPHAGE INFLAMMATORY PROTEIN-1; MALE; MIDDLE AGED; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLEURAL EFFUSION; PNEUMONIA, BACTERIAL; TISSUE PLASMINOGEN ACTIVATOR; TUBERCULOSIS, PLEURAL; TUMOR NECROSIS FACTOR-ALPHA;

EID: 21344439142     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clim.2005.03.015     Document Type: Article

References (33)

1. A. Herbert Pathogenesis of pleurisy, pleural fibrosis and mesothelial proliferation Thorax 41 1986 176 189
2. N.R. Barrett The pleura, with special reference to fibrothorax Thorax 25 1970 515 524
3. R.W. Light Pleural Diseases 4th ed. 2001 Lippincort Willians and Wilkins Philadelphia, PA 151 181
4. R.W. Light Pleural Diseases 4th ed. 2001 Lippincort Willians and Wilkins Philadelphia, PA 182 195
5. T.C. Bithell Blood coagulation G.R. Lee T.C. Bithell J. Foerster Wintrobe's Clinical Hematology 9th ed. 1993 Lea and Febugerm Philadelphia, PA 566 615
6. V. Argenius, J. Chmielewska, O. Widström, and M. Blombäck Pleural fibrinolytic activity is decreased in inflammation as demonstrated in quinacrine pleurodesis treatment of malignant pleural effusion Am. Rev. Respir. Dis. 140 1989 1381 1385
7. V. Agrenius, L.E. Gustafsson, and O. Widström Tumor necrosis factor-α and nitric oxide, determined as nitrate, in malignant pleural effusion Respir. Med. 88 1994 743 748
8. V. Agrenius, V. Ukale, O. Widström, G. Kallenius, and S.B. Svenson Quinacrine-induced pleural inflammation in malignant pleurisy: relation between drainage time of pleural fluid and local interleukin-1β Respiration 60 1993 366 372
9. S. Idell, W. Girard, K.B. Koenig, J. Mclarty, and D.S. Fair Abnormalities of pathways of fibrin turnover in the human pleural space Am. Rev. Respir. Dis. 144 1991 187 194
10. S. Idell, C. Zwieb, A. Kumar, K.B. Koenig, and A.R. Johnson Pathway of fibrin turnover of human pleural mesothelial cells in vitro Am. J. Respir. Cell Mol. Biol. 7 1992 414 426
11. S.A. Whawell, and J.N. Thompson Cytokine-induced release of plasminogen activator inhibitor-1 by human mesothelial cells Eur. J. Surg. 161 1995 315 317
12. S.A. Whawell, D.M. Scott-Coombes, M.N. Vipond, S.J. Tebbutt, and J.N. Thompson Tumour necrosis factor-mediated release of plasminogen activator inhibitor 1 by human peritoneal mesothelial cells Br. J. Surg. 81 1994 214 216
13. V.W.M. Van Hinsbergh, T. Kooistra, E.A. Van den Berg, H.M.G. Princen, W. Fiers, and J.J. Emeis Tumor necrosis factor increases the production of plasminogen activator inhibitor in human endothelial cells in vitro and in rats in vivo Blood 72 1988 1467 1473
14. S. Fujino, A. Yokoyama, N. Kohno, and K. Hiwada Interleukin 6 is an autocrine growth factor for normal human pleural mesothelial cells Am. J. Respir. Cell Mol. Biol. 14 1996 508 515
15. V.B. Antony, J.W. Hott, S.L. Kunkel, S.W. Godbey, M.D. Burdick, and R.M. Strieter Pleural mesothelial cell expression of C-C (monocyte chemotactic peptide) and C-X-C (interleukin 8) chemokines Am. J. Respir. Cell Mol. Biol. 12 1995 581 588
16. V.B. Antony Immunologic mechanisms in pleural disease Eur. Respir. J. 21 2003 539 544
17. C.C. Hua, L.C. Chang, Y.C. Chen, and S.C. Chang Proinflammatory cytokines and fibrinolytic enzymes in tuberculous and malignant pleural effusions Chest 116 1999 1292 1296
18. A. de Pablo, V. Villena, J. Echave-Sustaeta, and A.L. Encuentra Are pleural fluid parameters related to the development of residual pleural thickening in tuberculosis? Chest 112 1997 1293 1297
19. R.W. Light Parapneumonic effusions and empyema Clin. Chest Med. 6 1985 55 62
20. G.L. Colice, A. Crutis, J. Deslauriers, J. Heffner, R. Light, B. Littenberg, S. Sahn, R.A. Weinstein, and R.D. Yusen Medical and surgical treatment of parapneumonic effusions. An evidence-based guideline Chest 18 2000 1158 1171
21. A.D. Luster Chemokines: chemotactic cytokines that mediate inflammation N. Engl. J. Med. 338 1998 436 445
22. V.B. Antony, S.W. Godbey, S.L. Kunkel, J.W. Hott, D.L. Hartman, M.D. Burdick, and R.M. Strieter Recruitment of inflammatory cells to the pleural space. Chemotactic cytokines, IL-8, and monocyte chemotactic peptide-1 in human pleural fluids J. Immunol. 151 1993 7216 7223
23. E.J. Miller, and S. Idell Interleukin-8: an important neutrophils chemotaxin in some cases of exudative pleural effusions Exp. Lung Res. 19 1993 589 601
24. F. Philip-Joët, M.C. Alessi, C. Philip-Joët, M. Aillaud, J.R. Barriere, A. Arnaud, and I. Juhan-Vague Fibrinolytic and inflammatory processes in pleural effusions Eur. Respir. J. 8 1995 1352 1356
25. C. Aleman, J. Alegre, J. Monasterio, R.M. Segura, L. Armadans, A. Angles, E. Varela, E. Ruiz, and T. Fernandez de Sevilla Association between inflammatory mediators and the fibrinolysis system in infectious pleural effusions Clin. Sci. 105 2003 601 607
26. N. Xirouchaki, N. Tzanakis, D. Bouros, D. Kyriakou, N. Karkavitsas, M. Alexandrakis, and N.M. Siafakas Diagnostic value of interleukin-1α, interleukin-6, and tumor necrosis factor in pleural effusions Chest 121 2002 815 820
27. A. Yokoyama, M. Maruyama, M. Ito, N. Kohno, K. Hiwada, and S. Yano Interleukin 6 activity in pleural effusion: Its diagnostic value and thrombopoietic activity Chest 102 1992 1055 1059
28. H. Yanagawa, S. Yano, T. Haku, Y. Ohmoto, and S. Sone Interleukin-1 receptor antagonist in pleural effusion due to inflammatory and malignant lung disease Eur. Respir. J. 9 1996 1211 1216
29. C. Silva-Mejías, F. Gamboa-Antiňolo, L.F. López-Cortés, M. Cruz-Ruiz, and J. Pachón Interleukin-1β in pleural fluids of different etiologies: its role as inflammatory mediator in empyema Chest 108 1995 942 945
30. B.J. Biemond, M. Levi, C.H. Ten, T. Van der Poll, H.R. Buller, C.E. Hack, and J.W. Ten Cate Plasminogen activator and plasminogen activator inhibitor I release during experimental endotoxaemia in chimpanzees: effect of interventions in the cytokines and coagulation cascades Clin. Sci. 88 1995 587 594
31. C.H. Lee, W.J. Wang, R.S. Lan, Y.H. Tsai, and Y.C. Chiang Corticosteroids in the treatment of tuberculous pleurisy: a double-blond, placebo-controlled, randomized study Chest 94 1988 1256 1259
32. C.S.V. Barbas, A. Cukier, C.R.R. de Varvalho, J.V.B. Filho, and R.W. Light The relationship between pleural fluid findings and the development of pleural thickening in patients with pleural tuberculosis Chest 100 1991 1264 1267
33. E. Kunter, A. Ilvan, and E. Kilic The effect of pleural fluid content on the development of pleural thickness Int. J. Tuberc. Lung Dis. 6 2002 516 522